Industrial - Machinery
Compare Stocks
5 / 10Stock Comparison
LASE vs IPGP vs LITE vs NPKI vs COHR
Revenue, margins, valuation, and 5-year total return — side by side.
Semiconductors
Communication Equipment
Oil & Gas Equipment & Services
Hardware, Equipment & Parts
LASE vs IPGP vs LITE vs NPKI vs COHR — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Industrial - Machinery | Semiconductors | Communication Equipment | Oil & Gas Equipment & Services | Hardware, Equipment & Parts |
| Market Cap | $19M | $4.43B | $64.50B | $1.26B | $53.16B |
| Revenue (TTM) | $7M | $1.04B | $2.49B | $287M | $1.81T |
| Net Income (TTM) | $-8M | $29M | $440M | $36M | $191.68B |
| Gross Margin | 31.1% | 37.6% | 37.7% | 35.2% | 0.1% |
| Operating Margin | -126.5% | 0.3% | 9.5% | 11.4% | 0.0% |
| Forward P/E | — | 78.1x | 110.1x | 28.1x | 61.6x |
| Total Debt | $5M | $0.00 | $2.61B | $37M | $3.89B |
| Cash & Equiv. | $534K | $404M | $521M | $5M | $909M |
LASE vs IPGP vs LITE vs NPKI vs COHR — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Nov 24 | May 26 | Return |
|---|---|---|---|
| Laser Photonics Cor… (LASE) | 100 | 15.6 | -84.4% |
| IPG Photonics Corpo… (IPGP) | 100 | 133.9 | +33.9% |
| Lumentum Holdings I… (LITE) | 100 | 1038.8 | +938.8% |
| NPK International I… (NPKI) | 100 | 178.8 | +78.8% |
| Coherent, Inc. (COHR) | 100 | 334.7 | +234.7% |
Price return only. Dividends and distributions are not included.
Quick Verdict: LASE vs IPGP vs LITE vs NPKI vs COHR
Each card shows where this stock fits in a portfolio — not just who wins on paper.
LASE is the clearest fit if your priority is income & stability.
- Dividend streak 2 yrs, beta 1.81
IPGP is the clearest fit if your priority is defensive.
- Beta 1.68, current ratio 6.08x
LITE carries the broadest edge in this set and is the clearest fit for long-term compounding.
- 36.8% 10Y total return vs COHR's 15.5%
- 17.7% margin vs LASE's -105.4%
- +12.8% vs LASE's -69.6%
- 8.5% ROA vs LASE's -43.1%, ROIC -4.3% vs -42.1%
NPKI is the #2 pick in this set and the best alternative if growth exposure and sleep-well-at-night is your priority.
- Rev growth 27.4%, EPS growth 124.0%, 3Y rev CAGR 12.8%
- Lower volatility, beta 1.27, Low D/E 10.4%, current ratio 1.43x
- 27.4% revenue growth vs LASE's -13.3%
- Lower P/E (28.1x vs 61.6x)
COHR ranks third and is worth considering specifically for dividends.
- 0.0% yield; the other 4 pay no meaningful dividend
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 27.4% revenue growth vs LASE's -13.3% | |
| Value | Lower P/E (28.1x vs 61.6x) | |
| Quality / Margins | 17.7% margin vs LASE's -105.4% | |
| Stability / Safety | Beta 1.27 vs COHR's 2.82, lower leverage | |
| Dividends | 0.0% yield; the other 4 pay no meaningful dividend | |
| Momentum (1Y) | +12.8% vs LASE's -69.6% | |
| Efficiency (ROA) | 8.5% ROA vs LASE's -43.1%, ROIC -4.3% vs -42.1% |
LASE vs IPGP vs LITE vs NPKI vs COHR — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
LASE vs IPGP vs LITE vs NPKI vs COHR — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
LITE leads in 2 of 6 categories
NPKI leads 2 • LASE leads 1 • IPGP leads 0 • COHR leads 0 • 1 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
LITE leads this category, winning 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
COHR is the larger business by revenue, generating $1.81T annually — 253540.9x LASE's $7M. LITE is the more profitable business, keeping 17.7% of every revenue dollar as net income compared to LASE's -105.4%. On growth, COHR holds the edge at +1204.5% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $7M | $1.0B | $2.5B | $287M | $1.81T |
| EBITDAEarnings before interest/tax | -$8M | $55M | $425M | $53M | $913M |
| Net IncomeAfter-tax profit | -$8M | $29M | $440M | $36M | $191.7B |
| Free Cash FlowCash after capex | -$4M | $8M | $399M | $32M | -$537.2B |
| Gross MarginGross profit ÷ Revenue | +31.1% | +37.6% | +37.7% | +35.2% | +0.1% |
| Operating MarginEBIT ÷ Revenue | -126.5% | +0.3% | +9.5% | +11.4% | +0.0% |
| Net MarginNet income ÷ Revenue | -105.4% | +2.8% | +17.7% | +12.4% | +10.6% |
| FCF MarginFCF ÷ Revenue | -58.7% | +0.8% | +16.0% | +11.1% | -29.7% |
| Rev. Growth (YoY)Latest quarter vs prior year | +28.3% | +16.6% | +90.1% | +15.9% | +1204.5% |
| EPS Growth (YoY)Latest quarter vs prior year | -7.4% | -54.4% | +3.3% | 0.0% | +11190.8% |
Valuation Metrics
NPKI leads this category, winning 3 of 6 comparable metrics.
Valuation Metrics
At 35.6x trailing earnings, NPKI trades at a 99% valuation discount to LITE's 2441.7x P/E. On an enterprise value basis, NPKI's 17.9x EV/EBITDA is more attractive than LITE's 869.4x.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $19M | $4.4B | $64.5B | $1.3B | $53.2B |
| Enterprise ValueMkt cap + debt − cash | $24M | $4.0B | $66.6B | $1.3B | $56.1B |
| Trailing P/EPrice ÷ TTM EPS | -3.97x | 143.14x | 2441.70x | 35.60x | -644.73x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 78.05x | 110.06x | 28.08x | 61.57x |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | — | — |
| EV / EBITDAEnterprise value multiple | — | 50.42x | 869.35x | 17.92x | 50.93x |
| Price / SalesMarket cap ÷ Revenue | 5.68x | 4.42x | 39.21x | 4.56x | 9.15x |
| Price / BookPrice ÷ Book value/share | 1.08x | 2.09x | 55.41x | 3.65x | 6.12x |
| Price / FCFMarket cap ÷ FCF | — | — | — | 48.02x | 275.80x |
Profitability & Efficiency
NPKI leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
LITE delivers a 30.7% return on equity — every $100 of shareholder capital generates $31 in annual profit, vs $-184 for LASE. NPKI carries lower financial leverage with a 0.10x debt-to-equity ratio, signaling a more conservative balance sheet compared to LITE's 2.30x. On the Piotroski fundamental quality scale (0–9), LITE scores 7/9 vs LASE's 1/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | -183.5% | +1.4% | +30.7% | +10.3% | +6.9% |
| ROA (TTM)Return on assets | -43.1% | +1.2% | +8.5% | +8.5% | +4.4% |
| ROICReturn on invested capital | -42.1% | +0.6% | -4.3% | +9.9% | +3.6% |
| ROCEReturn on capital employed | -45.9% | +0.6% | -4.8% | +12.7% | +4.2% |
| Piotroski ScoreFundamental quality 0–9 | 1 | 6 | 7 | 7 | 7 |
| Debt / EquityFinancial leverage | 0.49x | — | 2.30x | 0.10x | 0.46x |
| Net DebtTotal debt minus cash | $4M | -$404M | $2.1B | $31M | $3.0B |
| Cash & Equiv.Liquid assets | $533,871 | $404M | $521M | $5M | $909M |
| Total DebtShort + long-term debt | $5M | $0 | $2.6B | $37M | $3.9B |
| Interest CoverageEBIT ÷ Interest expense | -6.60x | — | 9.62x | 77.08x | 0.01x |
Total Returns (Dividends Reinvested)
LITE leads this category, winning 6 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in LITE five years ago would be worth $111,852 today (with dividends reinvested), compared to $3,384 for LASE. Over the past 12 months, LITE leads with a +1275.9% total return vs LASE's -69.6%. The 3-year compound annual growth rate (CAGR) favors LITE at 166.2% vs LASE's -34.4% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -56.3% | +39.6% | +134.0% | +23.6% | +72.5% |
| 1-Year ReturnPast 12 months | -69.6% | +77.9% | +1275.9% | +85.5% | +374.9% |
| 3-Year ReturnCumulative with dividends | -71.7% | -10.2% | +1786.5% | +85.5% | +942.8% |
| 5-Year ReturnCumulative with dividends | -66.2% | -44.3% | +1018.5% | +85.5% | +440.7% |
| 10-Year ReturnCumulative with dividends | -66.2% | +23.6% | +3680.0% | +85.5% | +1545.8% |
| CAGR (3Y)Annualised 3-year return | -34.4% | -3.5% | +166.2% | +22.9% | +118.5% |
Risk & Volatility
Evenly matched — NPKI and COHR each lead in 1 of 2 comparable metrics.
Risk & Volatility
NPKI is the less volatile stock with a 1.27 beta — it tends to amplify market swings less than COHR's 2.82 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. COHR currently trades 91.9% from its 52-week high vs LASE's 12.9% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.81x | 1.68x | 2.66x | 1.27x | 2.82x |
| 52-Week HighHighest price in past year | $6.77 | $155.82 | $1021.00 | $16.50 | $364.80 |
| 52-Week LowLowest price in past year | $0.38 | $58.09 | $63.98 | $7.63 | $67.50 |
| % of 52W HighCurrent price vs 52-week peak | +12.9% | +67.1% | +88.5% | +90.6% | +91.9% |
| RSI (14)Momentum oscillator 0–100 | 37.5 | 39.5 | 53.3 | 53.6 | 53.1 |
| Avg Volume (50D)Average daily shares traded | 1.9M | 504K | 6.5M | 768K | 6.8M |
Analyst Outlook
LASE leads this category, winning 1 of 1 comparable metric.
Analyst Outlook
Analyst consensus: IPGP as "Buy", LITE as "Buy", NPKI as "Buy", COHR as "Buy". Consensus price targets imply 35.2% upside for IPGP (target: $141) vs -3.4% for COHR (target: $324).
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Buy | Buy | Buy | Buy |
| Price TargetConsensus 12-month target | — | $141.25 | $918.67 | — | $324.00 |
| # AnalystsCovering analysts | — | 27 | 25 | 3 | 30 |
| Dividend YieldAnnual dividend ÷ price | — | — | — | — | +0.0% |
| Dividend StreakConsecutive years of raises | 2 | 1 | 0 | 0 | 0 |
| Dividend / ShareAnnual DPS | — | — | — | — | $0.07 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +1.2% | +0.1% | +1.8% | +0.1% |
LITE leads in 2 of 6 categories (Income & Cash Flow, Total Returns). NPKI leads in 2 (Valuation Metrics, Profitability & Efficiency). 1 tied.
LASE vs IPGP vs LITE vs NPKI vs COHR: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is LASE or IPGP or LITE or NPKI or COHR a better buy right now?
For growth investors, NPK International Inc.
(NPKI) is the stronger pick with 27. 4% revenue growth year-over-year, versus -13. 3% for Laser Photonics Corporation (LASE). NPK International Inc. (NPKI) offers the better valuation at 35. 6x trailing P/E (28. 1x forward), making it the more compelling value choice. Analysts rate IPG Photonics Corporation (IPGP) a "Buy" — based on 27 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — LASE or IPGP or LITE or NPKI or COHR?
On trailing P/E, NPK International Inc.
(NPKI) is the cheapest at 35. 6x versus Lumentum Holdings Inc. at 2441. 7x. On forward P/E, NPK International Inc. is actually cheaper at 28. 1x.
03Which is the better long-term investment — LASE or IPGP or LITE or NPKI or COHR?
Over the past 5 years, Lumentum Holdings Inc.
(LITE) delivered a total return of +1019%, compared to -66. 2% for Laser Photonics Corporation (LASE). Over 10 years, the gap is even starker: LITE returned +36. 8% versus LASE's -66. 2%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — LASE or IPGP or LITE or NPKI or COHR?
By beta (market sensitivity over 5 years), NPK International Inc.
(NPKI) is the lower-risk stock at 1. 27β versus Coherent, Inc. 's 2. 82β — meaning COHR is approximately 122% more volatile than NPKI relative to the S&P 500. On balance sheet safety, NPK International Inc. (NPKI) carries a lower debt/equity ratio of 10% versus 2% for Lumentum Holdings Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — LASE or IPGP or LITE or NPKI or COHR?
By revenue growth (latest reported year), NPK International Inc.
(NPKI) is pulling ahead at 27. 4% versus -13. 3% for Laser Photonics Corporation (LASE). On earnings-per-share growth, the picture is similar: NPK International Inc. grew EPS 124. 0% year-over-year, compared to 40. 5% for Laser Photonics Corporation. Over a 3-year CAGR, COHR leads at 20. 5% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — LASE or IPGP or LITE or NPKI or COHR?
NPK International Inc.
(NPKI) is the more profitable company, earning 13. 0% net margin versus -73. 8% for Laser Photonics Corporation — meaning it keeps 13. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: NPKI leads at 16. 9% versus -189. 3% for LASE. At the gross margin level — before operating expenses — LASE leads at 43. 4%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is LASE or IPGP or LITE or NPKI or COHR more undervalued right now?
On forward earnings alone, NPK International Inc.
(NPKI) trades at 28. 1x forward P/E versus 110. 1x for Lumentum Holdings Inc. — 82. 0x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for IPGP: 35. 2% to $141. 25.
08Which pays a better dividend — LASE or IPGP or LITE or NPKI or COHR?
None of the stocks in this comparison currently pay a material dividend.
All are effectively zero-yield and should be held for capital appreciation rather than income.
09Is LASE or IPGP or LITE or NPKI or COHR better for a retirement portfolio?
For long-horizon retirement investors, Coherent, Inc.
(COHR) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (+1546% 10Y return). Lumentum Holdings Inc. (LITE) carries a higher beta of 2. 66 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (COHR: +1546%, LITE: +36. 8%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between LASE and IPGP and LITE and NPKI and COHR?
These companies operate in different sectors (LASE (Industrials) and IPGP (Technology) and LITE (Technology) and NPKI (Energy) and COHR (Technology)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: LASE is a small-cap quality compounder stock; IPGP is a small-cap quality compounder stock; LITE is a mid-cap high-growth stock; NPKI is a small-cap high-growth stock; COHR is a mid-cap high-growth stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.